Clinical Trial Update: Protective VEGF Inhibition for Isotoxic Dose Escalation in Glioblastoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update from University Hospital Tuebingen investigating protective VEGF inhibition for isotoxic dose escalation in glioblastoma; the stud…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Drugs mentioned

• Unspecified VEGF inhibitor

Snippet

Sponsor: University Hospital Tuebingen | Conditions: Glioblastoma | Phase 2 | Status: RECRUITING